Western blot analysis of key angiogenic factors HIF1A and VEGFA revealed that NF treatment resulted in decreased HIF1A and VEGFA levels in GBM cells (Additional file 2: Figure S4). The gene discussed is VEGFA; the disease is glioblastoma.